Workflow
Benchmark Electronics(BHE) - 2024 Q4 - Annual Report

Sales Performance - Sales for 2024 were 2.7billion,a62.7 billion, a 6% decrease from 2.8 billion in 2023, primarily due to decreases in medical and AC&C sales [173]. - Sales to the ten largest customers represented 50% of total sales in 2024, with the largest customer, Applied Materials, accounting for 14% of total sales [174]. - Sales in the Semi-Cap sector increased by 12% to 723.2millionin2024,drivenbydemandfromexistingandnewcustomers[181].Medicalsalesdecreasedby19723.2 million in 2024, driven by demand from existing and new customers [181]. - Medical sales decreased by 19% to 450.7 million in 2024, attributed to inventory rebalancing and end-demand weakness [182]. Financial Performance - Net income for 2024 was 63.3million,or63.3 million, or 1.72 per diluted share, compared to 64.3million,or64.3 million, or 1.79 per diluted share, in 2023 [203]. - Gross profit margin increased to 10.2% in 2024 from 9.5% in 2023, despite gross profit remaining relatively consistent at 270.0million[188].OperatingincomeintheAmericasdecreasedby37270.0 million [188]. - Operating income in the Americas decreased by 37% to 40.2 million in 2024, primarily due to lower revenue [190]. - Interest expense decreased to 26.9millionin2024from26.9 million in 2024 from 31.9 million in 2023, mainly due to decreased borrowings [198]. Cash Flow and Investments - Cash and cash equivalents totaled 328.0millionatDecember31,2024,upfrom328.0 million at December 31, 2024, up from 283.2 million at December 31, 2023 [204]. - Cash provided from operating activities was 189.2millionin2024,consistingof189.2 million in 2024, consisting of 63.3 million net income and 46.1milliondepreciationandamortization[207].Cashusedininvestingactivitieswas46.1 million depreciation and amortization [207]. - Cash used in investing activities was 32.8 million in 2024, primarily for capital expenditures of 31.3millionforproperty,plant,andequipment[209].Cashusedinfinancingactivitieswas31.3 million for property, plant, and equipment [209]. - Cash used in financing activities was 109.1 million in 2024, including 600.0millioninborrowingsand600.0 million in borrowings and 674.1 million in principal payments under the Credit Agreement [210]. Capital Expenditures and Borrowings - The Company plans capital expenditures of approximately 65millionto65 million to 75 million over the next 12 months to increase production capacity [217]. - As of December 31, 2024, the Company had 123.0millioninborrowingsoutstandingunderthetermloanfacilityand123.0 million in borrowings outstanding under the term loan facility and 135.0 million under the revolving credit facility [215]. - The Company amended its Credit Agreement to increase the revolving credit facility commitments from 450millionto450 million to 550 million [214]. - As of December 31, 2024, the Company had 410.6millionavailableforborrowingsundertheCreditAgreement[217].ShareholderReturnsTheCompanyrepurchased0.1millionsharesfor410.6 million available for borrowings under the Credit Agreement [217]. Shareholder Returns - The Company repurchased 0.1 million shares for 5.1 million in 2024, with an average price of 40.27pershare[220].Cashdividendspaidin2024totaled40.27 per share [220]. - Cash dividends paid in 2024 totaled 23.9 million, compared to 23.5millionin2023and23.5 million in 2023 and 23.2 million in 2022 [221]. Risk Management - The company is exposed to foreign currency fluctuation risks and utilizes natural hedging and forward contracts to manage transactional exposure [241]. - Sales are primarily denominated in U.S. dollars, with foreign currency cash flows generated in certain European and Asian countries and Mexico [242]. - The company is also exposed to market risks related to interest rates on financial instruments, particularly on invested cash balances [243]. - The company does not use derivative financial instruments for speculative purposes, focusing instead on managing risks associated with foreign currency and interest rates [241]. Compliance and Obligations - The Company is in compliance with all financial covenants related to its Credit Agreement as of December 31, 2024 [216]. - The company has contractual obligations extending beyond 2024 related to lease obligations and debt arrangements, with some electronic component manufacturers experiencing lead-times exceeding 52 weeks due to supply chain constraints [236]. - The company has not guaranteed obligations of any entity outside of its wholly owned subsidiaries, maintaining a conservative financial approach [236]. Goodwill and Impairment - As of December 31, 2024, the fair value of the Americas and Asia reporting units was determined to be greater than their carrying amounts, indicating no further goodwill impairment testing was required [234]. - Changes in economic and operating conditions may lead to future goodwill impairment charges, highlighting the importance of ongoing assessments [234].